MSCM ventures into RM80BIL healthcare industry


(From left) GeneFlux Bioscience CEO Balaguru Naidu, MSCM Holdings executive chairman Datuk Teoh Hai Hin, MSCM Holdings executive director Jeff Chong, MMA president Dr Ganabaskaran Nadason and MMA honorary general secretary and Koperasi Persatuan Perubatan Malaysia chairman Dr Thirunavukarasu Rajoo at the agreement signing between MSCM Holdings subsidiary HS Bio Supplies and the cooperative on Aug 28,2020.

MSCM Holdings Berhad is venturing into medical supplies and support as it seeks to reduce reliance on its core business and tap into the RM80bil Malaysian healthcare industry.

The group through its subsidiary HS Bio Supplies Sdn Bhd (HSBS) intends to be involved in the business of trading and provision of bio supplies, healthcare products, medical equipment, supplements, test kits, vaccines, among others.

Limited time offer:
Just RM5 per month.

Monthly Plan

RM13.90/month
RM5/month

Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Business News

Trade showing remains on upward trajectory
Maxis pledges full support to government’s 5G delivery model
Fajarbaru Builder secures RM13mil job
MKH Oil Palm IPO oversubscribed
The pros and cons of earned wage access
Making every load lighter
Making the Malaysian startup pitch
How Sin-Kung leveraged air cargo for its success
Domestic office-sector REITs stay cautious
‘Muted optimism’

Others Also Read